DRUG APPROVALS: APRIL 2011
APRIL 6: HORIZANT (GABAPENTIN ENACARBIL)
TREATMENT- RESTLESS LEGS SYNDROME
APRIL 11: SYLATRON (PEGINTERFERON ALFA-2B)
TREATMENT- MALIGNANT MELANOMA
APRIL 23: DUEXIS (FAMOTIDINE & IBUPROFEN) TABLETS
TREATMENT- OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, NSAID-INDUCED ULCER PROPHYLAXIS
APRIL 28: ZYTIGA (ABIRATERONE) TABLETS
TREATMENT- PROSTATE CANCER